GL1X · GenesisL1 explorer

MolNFT v1 · #118361 · protein

Crystal structure of Fab of parasite invasion inhibitory antibody C1 - hexagonal form

5EZI · Fab C12 heavy chain: “Crystal structure of Fab of parasite invasion inhibitory antibody C1 - hexagonal form”. X-ray diffraction, 6 ligands (NAG, MAN, BMA), 4 pockets (best druggability 0.60). MolNFT v1 #118361 on GenesisL1: 3D…

PDB
5EZI
Type
protein
Length
436 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab C12 heavy chain; Fab C12 light chain
Ligands
NAG, MAN, BMA, GAL, FUC, CL
Pockets
4 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HFab C12 heavy chainprotein2227% helix, 51% strand—
LFab C12 light chainprotein2146% helix, 52% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains H
  • MAN · alpha-D-mannopyranose · sugar · 2 copies
  • BMA · beta-D-mannopyranose · sugar
  • GAL · beta-D-galactopyranose · sugar
  • FUC · alpha-L-fucopyranose · sugar · chains H
  • CL · Chloride ion · ion · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15200.600.7458empty
2740.310.7419empty
3790.310.7421CL
4730.300.7320empty

Interfaces

1 interface between chains.

  • H–L · 1935 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 5EZI · Crystal Structure of Fab of parasite invasion inhibitory antibody c1 - hexagonal form · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.